Ep. 126 - Growing Galapagos, Plus Abortion & Biopharma

from BioCentury This Week · host BioCentury

On the latest BioCentury This Week podcast, a pair of deals demonstrates how Galapagos CEO Paul Stoffels is shifting the Belgian biotech’s strategic focus from small molecules toward a diversified portfolio. Plus: why Friday’s Supreme Court decision to overturn Roe v. Wade sets the stage for legal and legislative battles that could have broad implications for biopharma and how a new crop of Indian biotechs are seeking to offer dramatically cheaper CAR T therapies. This week’s podcast is sponsored by the BioCentury-BayHelix East-West Summit 2022.Reach us by sending a text

Episode metadata supplied by the publisher feed · Published Jun 28, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep. 126 - Growing Galapagos, Plus Abortion & Biopharma

0:00 25:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioCentury This Week?

This episode is 25 minutes long.

When was this BioCentury This Week episode published?

This episode was published on June 28, 2022.

Can I download this BioCentury This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!